Research Article
Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis
Table 1
Characteristics of included studies.
| Study | Sample size (n) | Type of operation | Experiment group | Control group | Sample size (n1) | Age (year) | Time of intervention and type of anesthesia | Injectate | Sample size (n2) | Age (year) | Time of intervention and type of anesthesia | Injectate |
| Aliste et al. 2021 [5] | 40 | Hip arthroplasty | 20 | 56.80 ± 13.00 | PENG after operation | 20 ml 0.50% adrenalized levobupivacaine | 20 | 59.6 ± 9.2 | FICB after operation | 40 ml 0.25% adrenalized levobupivacaine | He et al. 2023 [14] | 60 | Hip fracture surgery | 30 | 72.31 ± 9.24 | PENG + DEX (iv.) before SA | 20 ml 0.2% ropivacaine 0.2 μg/kg dexmedetomidine (iv.) | 30 | 72.49 ± 8.92 | DEX (iv.) before SA | 0.2 μg/kg dexmedetomidine (iv.) | Huang et al. 2021 [15] | 100 | Hip arthroplasty | 50 | 76.50 ± 5.30 | PENG before SA | 20 ml 0.5% ropivacaine | 50 | 76.8 ± 5.0 | SF. before SA | 0.15 μg/kg sufentanil (iv.) | Hua et al. 2022 [13] | 48 | Hip arthroplasty | 24 | 74.00 ± 7.00 | PENG before SA | 20 ml 0.4% ropivacaine | 24 | 74 ± 8 | FICB before SA | 30 ml 0.4% ropivacaine hydrochloride | Jadon et al. 2021 [12] | 66 | Hip fracture | 33 | 70.39 ± 11.45 | PENG before SA | — | 33 | 67.87 ± 13.12 | FICB before SA | — | Mosaffa et al. 2020 [16] | 60 | Hip arthroplasty | 30 | 54.00 ± 11.00 | PENG before SA | 20 ml 0.25% bupivacaine | 30 | 57 ± 8 | N/A | N/A | Lin et al. 2022 [17] | 60 | Total hip arthroplasty | 30 | 68.60 ± 9.50 | PENG before SA | 20 ml 0.5% ropivacaine | 30 | 68.3 ± 10.9 | N/A | 20 ml saline | Mao et al. 2022 [18] | 120 | Hip arthroplasty | 60 | 74.75 ± 6.98 | PENG before SA | 20 ml 0.375% ropivacaine | 60 | 75.12 ± 7.49 | FICB before SA | 20 ml 0.375% ropivacaine | Mosaffa et al. 2022 [11] | 52 | Hip fracture | 30 | 53.00 ± 16.46 | PENG before SA | 3 ml/kg 0.5% ropivacaine | 22 | 50 ± 13.63 | FICB before SA | 3 ml/kg 0.5% ropivacaine | Natrajan et al. 2021 [10] | 24 | Dynamic hip screw fixation or hemiarthroplasty | 12 | — | PENG before SA | 20 ml 0.5% ropivacaine | 12 | — | FICB before SA | 20 ml 0.5% ropivacaine | Pascarella et al. 2021 [19] | 60 | Total hip arthroplasty | 30 | 66.40 ± 12.40 | PENG after SA | 20 ml 0.375% ropivacaine | 30 | 66.7 ± 8.6 | N/A | N/A | Senthil et al. 2021 [2] | 40 | Hip fracture | 20 | 53.90 ± 9.90 | PENG after operation | 30 ml 0.25% levobupivacaine with 4 mg dexamethasone | 20 | 52.5 ± 9.8 | FICB after operation | 30 ml 0.25% levobupivacaine with 4 mg dexamethasone | Shan et al. 2021 [20] | 40 | Hip arthroplasty | 20 | 71.40 ± 9.70 | PENG before SA | 10 ml 0.5% ropivacaine | 20 | 74.8 ± 7.6 | SF. before SA | 0.1 μg/kg sufentanil (iv.) | Wu et al. 2022 [21] | 40 | Hip arthroplasty | 20 | 75.80 ± 9.20 | PENG before SA | 20 ml 0.375% ropivacaine | 20 | 75.7 ± 8.9 | SF. before SA | 0.2 μg/kg sufentanil (iv.) | Zhang et al. 2022 [22] | 80 | Hip arthroplasty | 40 | 63.71 ± 6.96 | PENG after SA | 20 ml 0.4% ropivacaine | 40 | 63.61 ± 7.03 | SF. before SA | 0.1 μg/kg sufentanil (iv.) |
|
|